Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-serine in Hereditary Sensory Neuropathy Type 1
NCT06113055Phase 2Unknown
- Sponsor
- University College London
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-serine in hereditary sensory neuropathy type 1 (HSAN1), sponsored by University College London. Status: unknown.
02
Drugs
l-serine
03
Conditions
hereditary sensory neuropathy type 1 (HSAN1)
Beyond the preview
Go deeper on NCT06113055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06113055.